GAM Holding’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-83,940
| Closed | -$388K | – | 974 |
|
|
2019
Q1 | $388K | Hold |
83,940
| – | – | 0.02% | 682 |
|
|
2018
Q4 | $294K | Hold |
83,940
| – | – | 0.01% | 699 |
|
|
2018
Q3 | $846K | Hold |
83,940
| – | – | 0.03% | 522 |
|
|
2018
Q2 | $608K | Hold |
83,940
| – | – | 0.02% | 610 |
|
|
2018
Q1 | $507K | Hold |
83,940
| – | – | 0.02% | 623 |
|
|
2017
Q4 | $808K | Hold |
83,940
| – | – | 0.02% | 635 |
|
|
2017
Q3 | $745K | Hold |
83,940
| – | – | 0.03% | 389 |
|
|
2017
Q2 | $1.06M | Hold |
83,940
| – | – | 0.02% | 633 |
|
|
2017
Q1 | $882K | Hold |
83,940
| – | – | 0.01% | 676 |
|
|
2016
Q4 | $772K | Hold |
83,940
| – | – | 0.01% | 665 |
|
|
2016
Q3 | $989K | Hold |
83,940
| – | – | 0.02% | 615 |
|
|
2016
Q2 | $1.08M | Hold |
83,940
| – | – | 0.02% | 642 |
|
|
2016
Q1 | $1.34M | Hold |
83,940
| – | – | 0.02% | 571 |
|
|
2015
Q4 | $2.4M | Hold |
83,940
| – | – | 0.04% | 451 |
|
|
2015
Q3 | $2.39M | Hold |
83,940
| – | – | 0.04% | 436 |
|
|
2015
Q2 | $3.02M | Hold |
83,940
| – | – | 0.04% | 412 |
|
|
2015
Q1 | $2.44M | Hold |
83,940
| – | – | 0.04% | 463 |
|
|
2014
Q4 | $1.77M | Hold |
83,940
| – | – | 0.03% | 543 |
|
|
2014
Q3 | $1.63M | Hold |
83,940
| – | – | 0.02% | 568 |
|
|
2014
Q2 | $1.31M | Hold |
83,940
| – | – | 0.02% | 640 |
|
|
2014
Q1 | $1.74M | Hold |
83,940
| – | – | 0.03% | 541 |
|
|
2013
Q4 | $1.08M | Hold |
83,940
| – | – | 0.02% | 582 |
|
|
2013
Q3 | $978K | Hold |
83,940
| – | – | 0.02% | 665 |
|
|
2013
Q2 | $387K | Buy |
+83,940
| New | +$308K | 0.01% | 677 |
|
Other funds holding INSY
WS
GAM Holding's INSY Position: Q2 2019 in Review
GAM Holding sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 83,940 shares — an estimated $388K sold.
GAM Holding first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $3.02M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- GAM Holding reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- GAM Holding sold 83,940 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $388K.
- GAM Holding first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- GAM Holding's Insys Therapeutics, Inc. position peaked at $3.02M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on GAM Holding's 13F filing for Q2 2019, filed 12 Aug 2019.